Interactions between recreational cannabis use and cognitive function: lessons from functional magnetic resonance imaging
- PMID: 30426517
- PMCID: PMC6513728
- DOI: 10.1111/nyas.13990
Interactions between recreational cannabis use and cognitive function: lessons from functional magnetic resonance imaging
Abstract
Cannabis use is becoming increasingly popular as a growing number of states pass legislation to legalize cannabis and cannabis-derived products for recreational and/or medical purposes. Given the widespread use of cannabis, it is critical to understand the neural consequences related to cannabis use. In this review, we focus on evidence from functional magnetic resonance imaging studies that document acute and residual alterations in brain function during tasks spanning a variety of cognitive domains: executive function, attention and working memory, memory, motor skills, error monitoring, and reward and affective processing. Although it is clear that cannabis affects brain function, the findings are somewhat inconsistent; variables that potentially affect study outcomes are outlined, including a discussion of the impact of chronological age and age of cannabis onset as well as length of abstinence at the time of assessment, which are important considerations when measuring cannabis use patterns. Inherent differences between recreational/adult cannabis use versus use for medical purposes are also discussed, given their importance to public policy decisions.
Keywords: cannabis; cognition; fMRI; marijuana; neuroimaging.
© 2018 New York Academy of Sciences.
Conflict of interest statement
Competing Interests
The authors declare no competing interests.
Similar articles
-
Early Cannabis Use and Neurocognitive Risk: A Prospective Functional Neuroimaging Study.Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Aug;3(8):713-725. doi: 10.1016/j.bpsc.2018.05.004. Epub 2018 May 29. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018. PMID: 30033100 Free PMC article.
-
Marijuana matters: reviewing the impact of marijuana on cognition, brain structure and function, & exploring policy implications and barriers to research.Int Rev Psychiatry. 2018 Jun;30(3):251-267. doi: 10.1080/09540261.2018.1460334. Epub 2018 Jul 3. Int Rev Psychiatry. 2018. PMID: 29966459 Free PMC article. Review.
-
Cognitive outcomes associated with long-term, regular, recreational cannabis use in adults: A meta-analysis.Exp Clin Psychopharmacol. 2020 Aug;28(4):471-494. doi: 10.1037/pha0000326. Epub 2019 Oct 31. Exp Clin Psychopharmacol. 2020. PMID: 31670548
-
Adverse Effects of Recreational and Medical Cannabis.Psychopharmacol Bull. 2021 Jan 12;51(1):94-109. Psychopharmacol Bull. 2021. PMID: 33897066 Free PMC article. Review.
-
Cerebellar alterations in cannabis users: A systematic review.Addict Biol. 2019 Nov;24(6):1121-1137. doi: 10.1111/adb.12714. Epub 2019 Feb 27. Addict Biol. 2019. PMID: 30811097
Cited by
-
Not Just a Pot: Visual Episodic Memory in Cannabis Users and Polydrug Cannabis Users: ROC and ERP Preliminary Investigation.Front Hum Neurosci. 2021 Jun 11;15:677793. doi: 10.3389/fnhum.2021.677793. eCollection 2021. Front Hum Neurosci. 2021. PMID: 34177497 Free PMC article.
-
Effects of cannabinoid exposure on short-term memory and medial orbitofrontal cortex function and chemistry in adolescent female rhesus macaques.Front Neurosci. 2022 Sep 30;16:998351. doi: 10.3389/fnins.2022.998351. eCollection 2022. Front Neurosci. 2022. PMID: 36248648 Free PMC article.
-
Theta and Alpha Oscillatory Activity During Working Memory Maintenance in Long-Term Cannabis Users: The Importance of the Polydrug Use Context.Front Hum Neurosci. 2021 Oct 18;15:740277. doi: 10.3389/fnhum.2021.740277. eCollection 2021. Front Hum Neurosci. 2021. PMID: 34733146 Free PMC article.
-
Implications of Medical and Recreational Marijuana Laws for Neuroscience Research: a Review.Curr Behav Neurosci Rep. 2020 Dec;7(4):258-266. doi: 10.1007/s40473-020-00222-5. Epub 2020 Oct 20. Curr Behav Neurosci Rep. 2020. PMID: 34336547 Free PMC article.
-
Marijuana: A systems-based primer of adverse effects associated with use and an overview of its therapeutic utility.SAGE Open Med. 2021 Mar 9;9:20503121211000909. doi: 10.1177/20503121211000909. eCollection 2021. SAGE Open Med. 2021. PMID: 33786179 Free PMC article. Review.
References
-
- Gonsiorek W, Lunn C, Fan X, et al. 2000. Endocannabinoid 2-Arachidonyl Glycerol Is a Full Agonist through Human Type 2 Cannabinoid Receptor: Antagonism by Anandamide. Molecular Pharmacology. 57: 1045–1050. - PubMed
-
- Glass M, Dragunow M & Faull RL. 1997. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience. 77: 299–318. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical